D.E. Shaw & Co
TRIB

D.E. Shaw & Co’s Trinity Biotech TRIB Stock Holding History

D.E. Shaw & Co’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,922
Closed -$348K – 3985
2018
Q2 		$348K Hold
13,922
– – ﹤0.01% 3301
2018
Q1 		$358K Hold
13,922
– – ﹤0.01% 3057
2017
Q4 		$356K Sell
13,922
-23,801
-63% -$614K ﹤0.01% 3161
2017
Q3 		$1.06M Sell
37,723
-34,675
-48% -$967K ﹤0.01% 2458
2017
Q2 		$2.17M Sell
72,398
-70
-0.1% -$1.98K ﹤0.01% 1922
2017
Q1 		$2.16M Buy
72,468
+14,485
+25% +$453K ﹤0.01% 1793
2016
Q4 		$2.01M Buy
57,983
+44,425
+328% +$1.53M ﹤0.01% 2004
2016
Q3 		$896K Buy
13,558
+1,370
+11% +$85.3K ﹤0.01% 2458
2016
Q2 		$691K Buy
12,188
+3,393
+39% +$191K ﹤0.01% 2632
2016
Q1 		$513K Buy
8,795
+5,366
+156% +$285K ﹤0.01% 2771
2015
Q4 		$202K Sell
3,429
-4,619
-57% -$273K ﹤0.01% 3558
2015
Q3 		$460K Sell
8,048
-1,174
-13% -$94.5K ﹤0.01% 3116
2015
Q2 		$833K Buy
9,222
+2,949
+47% +$255K ﹤0.01% 2832
2015
Q1 		$604K Buy
6,273
+3,826
+156% +$354K ﹤0.01% 2941
2014
Q4 		$214K Sell
2,447
-4,862
-67% -$419K ﹤0.01% 3780
2014
Q3 		$668K Sell
7,309
-3,463
-32% -$375K ﹤0.01% 3134
2014
Q2 		$1.24M Buy
10,772
+3,205
+42% +$380K ﹤0.01% 2737
2014
Q1 		$917K Buy
7,567
+2,673
+55% +$350K ﹤0.01% 3111
2013
Q4 		$615K Buy
4,894
+462
+10% +$55.5K ﹤0.01% 3568
2013
Q3 		$482K Sell
4,432
-7,531
-63% -$734K ﹤0.01% 3602
2013
Q2 		$1.01M Buy
+11,963
New +$992K ﹤0.01% 2704

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

D.E. Shaw & Co's TRIB Position: Q3 2018 in Review

D.E. Shaw & Co sold out of Trinity Biotech (TRIB) in Q3 2018, closing a stake of 13,922 shares — an estimated $348K sold.

D.E. Shaw & Co first reported a position in TRIB in Q2 2013 and held it in 21 quarters. The position peaked at $2.17M in Q2 2017. 47 funds tracked by Wall St. Rank hold TRIB as of Q3 2018.

  • D.E. Shaw & Co reported no remaining Trinity Biotech position as of Q3 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 13,922 Trinity Biotech shares in Q3 2018, an estimated $348K.
  • D.E. Shaw & Co first reported a position in Trinity Biotech in Q2 2013 and held it in 21 quarters.
  • D.E. Shaw & Co's Trinity Biotech position peaked at $2.17M in Q2 2017.
  • 47 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2018.

Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.